© 2014-2018 Clarity Pharma Research LLC  |  All Rights Reserved Privacy Policy

To learn more about our services, call (864) 208-0078 or contact

Subscribe to our newsletter at:

    Clarity Pharma newsroom 


  • Clarity Pharma Research researchers have co-written a number of articles and poster presentations in the past 18 months, including for:

  • American Academy of Neurology, poster on treatment for rare infantile spasms, 60th annual meeting (April 20178, Boston); also published as abstract in Neurology supplement (April 2017)

  • ISPOR (International Society for Pharmacoeconomics and Outcomes Research), 2 poster presentations on findings from an economic burden of illness study of a rare lung infection in Europe and Canada (November 2016, Vienna, Austria) (This follows a presentation at the 2015 ISPOR conference in Milan, Italy.)
  • Rheumatology and Therapy, co-authors, article on utilization patterns and medical resource use of a product among patients with rheumatological diseases (December 2017; online October 2017)

Subscribe to our free educational bulletin to learn more about us and innovative ways to use patient records research! Click on the sun to register.

Please take a moment to view some of our past newsletters:
— Doctors Want Less Promotion and More Education  (view)
— Case Study: Propelling a Drug from Prelaunch to Blockbuster  (view)
— Gaining Market Access: Some Unexpected Help (view)
— Clarity’s Chief Scientist to Speak Again at EphMRA (view) 
— Evaluating Low-Information Markets with Delphi Method (view)
— Clarity Co-Authors KIT 2014 Presentation (view)
 Our Redesigned Web Site Has You in Mind (view)
— Why Peer-Reviewed Publications Matter (view)
 Meet the Elephant: Faster, Cheaper, Better? (view)
How Does Your Drug / Device Stack Up? Comparative Cost-
​     Effectiveness Research 
Correcting Claims Data with Patient Records Research  (view)
Sample Size: Sometimes Less IS More  (view)
Can Good Math Correct a Bad Study?  (view)

Is Your Market Research Costing You? (view)
Who Is Alf Landon? (And Why It Matters) (view)